
北米の非経口栄養市場の2030年までの予測 - 地域分析 - 栄養剤タイプ別(単回投与アミノ酸溶液、非経口脂質乳剤、炭水化物、微量元素、ビタミン・ミネラル)およびエンドユーザー別(病院、診療所、その他)
No. of Pages: 82 | Report Code: BMIRE00030516 | Category: Life Sciences
No. of Pages: 82 | Report Code: BMIRE00030516 | Category: Life Sciences
1. ICU Medical Inc
2. Grifols SA
3. Pfizer Inc
4. Otsuka Pharmaceuticals Co Ltd
5. Baxter International Inc
6. B Braun SE
7. Fresenius Kabi AG
8. Aculife Healthcare Pvt Ltd
9. Vifor Pharma Management AG
The North America Parenteral Nutrition Market is valued at US$ 3,012.06 Million in 2022, it is projected to reach US$ 4,805.31 Million by 2030.
As per our report North America Parenteral Nutrition Market, the market size is valued at US$ 3,012.06 Million in 2022, projecting it to reach US$ 4,805.31 Million by 2030. This translates to a CAGR of approximately 6.0% during the forecast period.
The North America Parenteral Nutrition Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Parenteral Nutrition Market report:
The North America Parenteral Nutrition Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Parenteral Nutrition Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Parenteral Nutrition Market value chain can benefit from the information contained in a comprehensive market report.